EGRIFTA WR (tesamorelin acetate)
GROWTH HORMONE MODULATORS · LIPODYSTROPHY ASSOCIATED WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION
THERATECHNOLOGI
Drug class
Growth Hormone Modulators
The term "growth hormone modulators" is a broad pharmacological descriptor rather than a single standardized FDA drug class, encompassing agents that alter the somatotropic (growth hormone/insulin-like growth factor-1) axis. Read more about Growth Hormone Modulators
19 drugs in this class 11 manufacturers
Drugs in Growth Hormone Modulators
Filter & compare in the drug finder →
Opens the drug finder with Growth Hormone Modulators preselected. Add indication or manufacturer filters there.
The term "growth hormone modulators" is a broad pharmacological descriptor rather than a single standardized FDA drug class, encompassing agents that alter the somatotropic (growth hormone/insulin-like growth factor-1) axis.
This category includes recombinant human growth hormone agonists (such as somatropin) that stimulate growth hormone receptors, growth hormone receptor antagonists (such as pegvisomant) that block peripheral receptor activation, and hypothalamic releasing-factor analogs that regulate endogenous hormone secretion.
Therapeutically, these agents are primarily indicated to manage pediatric and adult growth hormone deficiencies, short stature associated with conditions like Turner syndrome, and catabolic or wasting states, as well as to treat disorders of growth hormone excess such as acromegaly.
-
nih.gov
The term "growth hormone modulators" is a broad pharmacological descriptor rather than a single standardized FDA drug class, encompassing agents that alter the somatotropic (growth hormone/insulin-like growth factor-1) axis This category includes recombinant human growth hormone agonists (such as somatropin) that stimulate growth hormone receptors, growth hormone receptor antagonists (such as pegvisomant) that block peripheral receptor activation, and hypothalamic releasing-factor analogs that r...
-
nih.gov
The term "growth hormone modulators" is a broad pharmacological descriptor rather than a single standardized FDA drug class, encompassing agents that alter the somatotropic (growth hormone/insulin-like growth factor-1) axis
-
drugbank.com
This category includes recombinant human growth hormone agonists (such as somatropin) that stimulate growth hormone receptors, growth hormone receptor antagonists (such as pegvisomant) that block peripheral receptor activation, and hypothalamic releasing-factor analogs that regulate endogenous hormone secretion
-
rxlist.com
This category includes recombinant human growth hormone agonists (such as somatropin) that stimulate growth hormone receptors, growth hormone receptor antagonists (such as pegvisomant) that block peripheral receptor activation, and hypothalamic releasing-factor analogs that regulate endogenous hormone secretion
-
fda.gov
Therapeutically, these agents are primarily indicated to manage pediatric and adult growth hormone deficiencies, short stature associated with conditions like Turner syndrome, and catabolic or wasting states, as well as to treat disorders of growth hormone excess such as acromegaly
-
nih.gov
Therapeutically, these agents are primarily indicated to manage pediatric and adult growth hormone deficiencies, short stature associated with conditions like Turner syndrome, and catabolic or wasting states, as well as to treat disorders of growth hormone excess such as acromegaly
-
medlineplus.gov
Therapeutically, these agents are primarily indicated to manage pediatric and adult growth hormone deficiencies, short stature associated with conditions like Turner syndrome, and catabolic or wasting states, as well as to treat disorders of growth hormone excess such as acromegaly
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.